Skip to content

CorMedix CRMD Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Pfizer logo
PfizerPFE
Merck & Co. logo
Merck & Co.MRK
Merit Medical Systems logo
Merit Medical SystemsMMSI
ITG
Integer HoldingsITGR
IAR
Integra LifeSciencesIART
Emergent Biosolutions logo
Emergent BiosolutionsEBS

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOther.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's deferred tax assets and other non-current assets?
CorMedix (CRMD) reported deferred tax assets and other non-current assets of $616K in Q4 2025.
How has CorMedix's deferred tax assets and other non-current assets changed year-over-year?
CorMedix's deferred tax assets and other non-current assets increased by 16.7% year-over-year, from $528K to $616K.
What is the long-term trend for CorMedix's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), CorMedix's deferred tax assets and other non-current assets has grown at a 96.5% compound annual growth rate (CAGR), from $21K to $616K.